相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- 规格:
1 mg///5 mg
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
AQX-435
CAS No. : 1619983-52-6
MCE 国际站:AQX-435
产品活性:AQX-435 是一种有效的 SHIP1 (SH2 domain-containing inositol-5′-phosphatase 1) 激活剂。AQX-435 降低 B 细胞受体 (BCR) 下游 PI3K 活性,诱导恶性 B 细胞凋亡,减少淋巴瘤生长。
研究领域:Metabolic Enzyme/Protease | Apoptosis
作用靶点:Phosphatase | Apoptosis
In Vitro: AQX-435 reduces CLL cell viability in a dose-dependent manner.
AQX-435-induced (5-30 µM; 24 hours) apoptosis is mediated via caspases since AQX435 induced PARP cleavage.
AQX-435 effectively inhibits PI(3,4,5)P3-mediated signaling downstream of the BCR in CLL and DLBCL cells. AQX-435 and Ibrutinib combine effectively to enhanced inhibition of BCR signaling. AQX-435 induced TMD8 cell apoptosis in vitro with an IC50 of ~2 µM. AQX-435 reduces anti-IgM-induced AKT phosphorylation and induces apoptosis in DLBCL cells.
In Vivo: AQX-435 (10 mg/kg; i.p.; 5 days) significantly reduced the volume of TMD8 tumors.
AQX-435 (50 mg/kg; ip) inhibits DLBCL PDX tumors growth.
AQX-435 reduced AKT phosphorylation and growth of DLBCL in vivo and cooperated with ibrutinib for tumor growth inhibition.
相关产品:MG-132 | Doxorubicin hydrochloride | Bafilomycin A1 | LY294002 | Tamoxifen | Paclitaxel | Y-27632 | Acetylcysteine | Angiotensin II human | 2-Deoxy-D-glucose | Staurosporine | SB-431542 | Actinomycin D | Deferoxamine mesylate | Bortezomib | 5-Fluorouracil | Trametinib | Sorafenib | Oxaliplatin | Gemcitabine | Temozolomide | Rotenone | Mdivi-1 | Elesclomol | Ruxolitinib | Decitabine | SP600125 | MK-2206 dihydrochloride | Etoposide | Cyclosporin A
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验In Vitro Functional Study of miR-126 in Leukemia
MicroRNAs (miRNAs, miRs) are postulated to be important regulators in various cancers, including leukemia. In a large-scale miRNA expression profiling analysis of 435 human miRNAs in 52 acute myeloid leukemia (AML) samples, we found that miR
Cell Res,1992,201(2):417-435. [5]Tegelenbosch RAJ, De Rooij DG. A quantitative study of spermatogonial multiplication and stem cell renewal in the C3H/101F1 hybrid mouse[J]. Mutation Reserch,1993,290(1):193-200. [6]Dym M, Jia MC, Dirami G, et al
422 429 430 431 435 442 442 444 445 449 450 452 455 456 459 461 462 463 465 466 468 469 470 471 472 473 476 477 478 479 480 481 482 484 485 486 487 488 489 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 511 512 513 514 515
技术资料暂无技术资料 索取技术资料


















